Loading...

BNBX BNB PLUS CORP Capital Structure Changes 8-K Filing

BNB

BNBX

BNB PLUS CORP

(BNBX)

2025 8-K

Delisting Notice

Board Appointment

Director Resignation

Shareholder Meeting Results

Management Changes

New Stock Offering

Funding Announcement

Workforce Reduction

Securities Offering Announc...

Securities Offering Update

Earnings Report

Voluntary Delisting

Management Changes

Forced Delisting

Financial Statements

Nasdaq Compliance

Annual Meeting Notice

Stockholder Meeting

Stockholder Meeting

Earnings Announcement

Special Meeting Update

Investor Presentation

Management Changes

Nasdaq Compliance Notice

Bylaw Amendments

Annual Meeting Results

Nasdaq Compliance

Earnings Reports

Special Meeting of Stockhol...

Delisting - Non-Compliance ...

Compliance with Nasdaq List...

Investment Agreement

Financial Results

Regulation FD Disclosure

Reverse Stock Split

Warrant Amendments

Special Meeting Approval

Earnings Reports

Registered Direct Offering

Termination of Equity Distr...

Salary Reductions

Earnings Reports

Equity Distribution Agreement

Annual Meeting Results

Earnings Reports

Departure of Directors

Earnings Reports

Contract Termination

Restricted Stock Unit Awards

Lease Agreements

Earnings Reports

External Links:

On September 29, 2025, Applied DNA Sciences Inc. announced a securities offering to sell approximately 4.62 million shares at $3.32 each, aiming for gross proceeds of around $27 million, and appointed Clay Shorrock as CEO, effective the same day.

AI Assistant

BNB PLUS CORP

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.